SCORES HOLDING CO INC

2022 Q3 Form 10-Q Financial Statement

#000141057824001023 Filed on June 20, 2024

View on sec.gov

Income Statement

Concept 2022 Q3

Balance Sheet

Concept 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.72K
YoY Change -81.59%
Cash & Equivalents $13.72K
Short-Term Investments
Other Short-Term Assets $63.48K
YoY Change 0.09%
Inventory
Prepaid Expenses $63.48K
Receivables $7.499K
Other Receivables $0.00
Total Short-Term Assets $84.70K
YoY Change -65.14%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $84.70K
Total Long-Term Assets $0.00
Total Assets $84.70K
YoY Change -65.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $200.2K
YoY Change -10.0%
Accrued Expenses $0.00
YoY Change -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $45.00K
YoY Change -72.73%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $245.2K
YoY Change -67.98%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $452.0K
YoY Change 35.53%
Total Long-Term Liabilities $452.0K
YoY Change 35.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $245.2K
Total Long-Term Liabilities $452.0K
Total Liabilities $697.2K
YoY Change -36.57%
SHAREHOLDERS EQUITY
Retained Earnings -$6.836M
YoY Change -3.44%
Common Stock $6.223M
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$612.5K
YoY Change
Total Liabilities & Shareholders Equity $84.70K
YoY Change -65.14%

Cashflow Statement

Concept 2022 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Notes Payable Current Related Party Type Extensible Enumeration
NotesPayableCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2021Q4 us-gaap Notes Payable Current Related Party Type Extensible Enumeration
NotesPayableCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Registrant Name
EntityRegistrantName
SCORES HOLDING CO INC
dei Entity Central Index Key
EntityCentralIndexKey
0000831489
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Trading Symbol
TradingSymbol
SCRH
CY2022Q3 us-gaap Other Liability Related Party Type Extensible Enumeration
OtherLiabilityRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2021Q4 us-gaap Other Liability Related Party Type Extensible Enumeration
OtherLiabilityRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-16665
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
UT
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0426358
dei Entity Address Address Line1
EntityAddressAddressLine1
34-35 Steinway Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Long Island City
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
11101
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
246-9090
dei Security12b Title
Security12bTitle
None
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
165186144
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13717
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33353
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2022Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
7499
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
140000
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
63479
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
38051
CY2022Q3 us-gaap Assets Current
AssetsCurrent
84695
CY2021Q4 us-gaap Assets Current
AssetsCurrent
211404
CY2022Q3 us-gaap Assets
Assets
84695
CY2021Q4 us-gaap Assets
Assets
211404
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
200152
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
213937
CY2022Q3 scrh Accrued Related Parties Expenses Current
AccruedRelatedPartiesExpensesCurrent
0
CY2021Q4 scrh Accrued Related Parties Expenses Current
AccruedRelatedPartiesExpensesCurrent
374346
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
45000
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
187500
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
245152
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
775783
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
452000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
351000
CY2022Q3 us-gaap Liabilities
Liabilities
697152
CY2021Q4 us-gaap Liabilities
Liabilities
1126783
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
165186144
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
165186144
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
165186144
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
165186144
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
165186
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
165186
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
6058117
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
6058117
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6835760
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7138682
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-612457
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-915379
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
84695
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
211404
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
73500
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
62000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
561000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
182001
CY2022Q3 us-gaap Revenues
Revenues
73500
CY2021Q3 us-gaap Revenues
Revenues
62000
us-gaap Revenues
Revenues
561000
us-gaap Revenues
Revenues
182001
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
77344
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
65461
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
252786
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
257701
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3844
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3461
us-gaap Operating Income Loss
OperatingIncomeLoss
308214
us-gaap Operating Income Loss
OperatingIncomeLoss
-75700
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-392
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-4049
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-5292
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-12009
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-392
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4049
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5292
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12009
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4236
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7510
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
302922
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-87709
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-4236
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-7510
us-gaap Net Income Loss
NetIncomeLoss
302922
us-gaap Net Income Loss
NetIncomeLoss
-87709
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.000
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.000
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.002
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.002
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.001
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.001
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
165186144
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
165186144
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
165186144
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
165186144
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
165186144
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
165186144
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
165186144
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
165186144
us-gaap Net Income Loss
NetIncomeLoss
302922
us-gaap Net Income Loss
NetIncomeLoss
-87709
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-132501
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
63403
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
25428
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
26176
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-13785
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
53732
scrh Increase Decrease In Accrued Expenses Related Parties
IncreaseDecreaseInAccruedExpensesRelatedParties
0
scrh Increase Decrease In Accrued Expenses Related Parties
IncreaseDecreaseInAccruedExpensesRelatedParties
67500
scrh Increase Decrease In Accrued Interest Related Parties
IncreaseDecreaseInAccruedInterestRelatedParties
0
scrh Increase Decrease In Accrued Interest Related Parties
IncreaseDecreaseInAccruedInterestRelatedParties
10935
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
101000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
98500
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-142500
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
354710
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
53379
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
374346
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-374346
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-19636
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
53379
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33353
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21143
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13717
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74522
us-gaap Interest Paid Net
InterestPaidNet
49765
us-gaap Interest Paid Net
InterestPaidNet
1074
us-gaap Income Taxes Paid
IncomeTaxesPaid
639
us-gaap Income Taxes Paid
IncomeTaxesPaid
350
scrh Supplemental Disclosure Of Cash Flows From Noncash Investing And Financing Activities
SupplementalDisclosureOfCashFlowsFromNoncashInvestingAndFinancingActivities
0
scrh Supplemental Disclosure Of Cash Flows From Noncash Investing And Financing Activities
SupplementalDisclosureOfCashFlowsFromNoncashInvestingAndFinancingActivities
0
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-768357
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-37311
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-805668
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-42888
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-848556
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-7510
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-856066
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-915379
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
311442
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-603937
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-4284
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-608221
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-4236
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-612457
scrh Unusual Or Infrequent Item Or Both Cash Proceeds
UnusualOrInfrequentItemOrBothCashProceeds
235000
scrh Unusual Or Infrequent Item Or Both Cash Proceeds
UnusualOrInfrequentItemOrBothCashProceeds
249000
scrh Unusual Or Infrequent Item Or Both Cash Proceeds
UnusualOrInfrequentItemOrBothCashProceeds
858000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6835760
scrh Working Capital Surplus Deficit
WorkingCapitalSurplusDeficit
-160457
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">The Company received royalty revenues from </span><span style="font-weight:normal;">5</span><span style="font-weight:normal;"> licensees during the 9 months ended September 30, 2022.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">With regards to September 30, 2022, concentrations of revenue from </span><span style="font-weight:normal;">four</span><span style="font-weight:normal;"> licensees for </span><span style="font-weight:normal;">12%</span><span style="font-weight:normal;"> and </span><span style="font-weight:normal;">44%</span><span style="font-weight:normal;">, totaling </span><span style="font-weight:normal;">92%</span><span style="font-weight:normal;">. There is </span><span style="font-weight:normal;">one</span><span style="font-weight:normal;"> receivable from a licensee totaling </span><span style="font-weight:normal;">100%</span><span style="font-weight:normal;">. There are </span><span style="font-weight:normal;">no</span><span style="font-weight:normal;"> revenues or receivables from these licensees that are considered related parties.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">With regards to September 30, 2021, concentrations of revenue from </span><span style="font-weight:normal;">two</span><span style="font-weight:normal;"> licensees for </span><span style="font-weight:normal;">40%</span><span style="font-weight:normal;"> to </span><span style="font-weight:normal;">58%</span><span style="font-weight:normal;">, totaling </span><span style="font-weight:normal;">98%</span><span style="font-weight:normal;">. There is </span><span style="font-weight:normal;">one</span><span style="font-weight:normal;"> receivable from a licensee totaling </span><span style="font-weight:normal;">100%</span><span style="font-weight:normal;">. There are </span><span style="font-weight:normal;">no</span><span style="font-weight:normal;"> revenues or receivables from licensees that are considered related parties.</span></p>
CY2022Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
0
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
0
CY2022Q3 us-gaap Revenues
Revenues
73500
CY2021Q3 us-gaap Revenues
Revenues
62000
us-gaap Revenues
Revenues
561000
us-gaap Revenues
Revenues
182001
CY2022Q3 us-gaap Revenues
Revenues
73500
CY2021Q3 us-gaap Revenues
Revenues
62000
us-gaap Revenues
Revenues
561000
us-gaap Revenues
Revenues
182001
CY2022Q3 us-gaap Trade Receivables Held For Sale Amount
TradeReceivablesHeldForSaleAmount
7499
CY2021Q4 us-gaap Trade Receivables Held For Sale Amount
TradeReceivablesHeldForSaleAmount
140000
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
452000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
351000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
351000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
235000
scrh Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
450000
CY2021 scrh Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
116000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-349000
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
452000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
351000
CY2017Q1 scrh Number Of Licenses With Settlement Agreements
NumberOfLicensesWithSettlementAgreements
3
CY2016Q2 us-gaap Loss Contingency Number Of Plaintiffs
LossContingencyNumberOfPlaintiffs
50
CY2018Q3 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
1310000
CY2022Q3 us-gaap Other Liabilities
OtherLiabilities
45000
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
561846
CY2022Q3 us-gaap Other Receivables
OtherReceivables
0
CY2021Q4 us-gaap Other Receivables
OtherReceivables
0
CY2024Q2 scrh Number Of License Agreements
NumberOfLicenseAgreements
6
CY2023Q2 us-gaap Loss On Contract Termination
LossOnContractTermination
45000
CY2016Q2 us-gaap Loss Contingency Number Of Plaintiffs
LossContingencyNumberOfPlaintiffs
50
CY2018Q3 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
1310000

Files In Submission

Name View Source Status
0001410578-24-001023-index-headers.html Edgar Link pending
0001410578-24-001023-index.html Edgar Link pending
0001410578-24-001023.txt Edgar Link pending
0001410578-24-001023-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20220930.xsd Edgar Link pending
tmb-20220930x10q.htm Edgar Link pending
tmb-20220930xex31d1.htm Edgar Link pending
tmb-20220930xex31d2.htm Edgar Link pending
tmb-20220930xex32d1.htm Edgar Link pending
tmb-20220930xex32d2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
tmb-20220930_cal.xml Edgar Link unprocessable
tmb-20220930_def.xml Edgar Link unprocessable
tmb-20220930_lab.xml Edgar Link unprocessable
tmb-20220930_pre.xml Edgar Link unprocessable
tmb-20220930x10q_htm.xml Edgar Link completed